Clinical Trials Sponsored by Clintrex Research Corporation

Total 715 results

Hamilton Health Sciences Corporation
Canadian Institutes of Health Research (CIHR); McMaster University

Completed

An Investigation Into Bone Micro-architecture in Women With Type 2 Diabetes

Type 2 Diabetes Mellitus

Canada
French National Agency for Research on AIDS and...
Chiron Corporation

Completed

Efficacy of Adding Interleukin-2 to an Optimized Antiretroviral Regimen in HIV Patients in Therapeutic Failure (ANRS123)

HIV Infections

France
French National Agency for Research on AIDS and...
Chiron Corporation

Completed

Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)

HIV Infections

France
Hamilton Health Sciences Corporation
Canadian Institutes of Health Research (CIHR)

Unknown

Long Study - Longitudinal Thrombosis in End Stage Renal Disease

Cardiovascular Disease | Thrombosis | Bleeding | End Stage Renal Disease

Canada
Hamilton Health Sciences Corporation
Canadian Institutes of Health Research (CIHR)

Completed

LOMA: Long-Term Management of Asthma

Asthma

Canada
ZonMw: The Netherlands Organisation for Health...
Boston Scientific Corporation

Completed

Emmy Trial: Uterine Artery Embolization (UAE) Versus Hysterectomy for Uterine Fibroids

Uterine Neoplasms | Leiomyoma | Menorrhagia

Netherlands
Hamilton Health Sciences Corporation
Canadian Institutes of Health Research (CIHR); AAAAI Foundation

Recruiting

Thresholds In Food Allergy evaluaTion And predictioN (TITAN)

Food Allergy | Tree Nut Allergy

Canada
SWOG Cancer Research Network
National Cancer Institute (NCI); Incyte Corporation; Ipsen; BeiGene

Recruiting

Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment

Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | High Grade B-Cell Lymphoma | Grade 3b Follicular Lymphoma | Transformed Non-Hodgkin Lymphoma | High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements

United States
European Association of Urology Research Foundation
Boston Scientific Corporation; Coloplast A/S

Recruiting

Registry for Patients Undergoing Penile Prosthesis Implantation for Male Erectile Dysfunction (PHOENIX)

Erectile Dysfunction

Spain, Belgium, France, Italy, Germany, United Kingdom, Portugal, Sweden
Humanetics Corporation
United States Department of Defense; Joint Warfighter Medical Research Program

Completed

BIO 300 Oral Powder Safety and Pharmacokinetics

Acute Radiation Syndrome

United States
Eli Lilly and Company
Algorithme Pharma Inc; CoLucid Pharmaceuticals; Cognitive Research Corporation

Completed

The Effects of Lasmiditan on Simulated Driving Performance - Healthy Participants

Migraine

Canada
Hamilton Health Sciences Corporation
Canadian Institutes of Health Research (CIHR)

Terminated

Canadian Pulmonary Embolism Diagnosis Study (CANPEDS)

Deep Venous Thrombosis | Suspected Pulmonary Embolism

Canada
Wake Forest University Health Sciences
Incyte Corporation; Amgen; Multiple Myeloma Research Consortium

Completed

LCI-HEM-MYE-CRD-004 (MMRC-073 CARJAK): Study of CRD for Carfilzomib-Refractory Multiple Myeloma

Multiple Myeloma

United States
Lawson Health Research Institute
Hamilton Health Sciences Corporation; London Health Sciences Centre

Completed

Prospective Validation of Circulating Tumor Cells & Circulating Endothelial Cells as Biomarkers in Renal Cancer

Clear Cell Renal Cancer | Circulating Tumor Cells | Predictive Biomarkers | Prognostic Biomarkers | Circulating Endothelial Cells

Canada
Medtronic Spinal and Biologics
Averion International Corporation; Baim Institute for Clinical Research

Withdrawn

Clinical Study of INFUSE® Bone Graft Compared to Autogenous Bone Graft for Vertical Ridge Augmentation

Alveolar Bone Loss in Mandible | Edentulous Alveolar Ridge In Mandible
Hamilton Health Sciences Corporation
Canadian Institutes of Health Research (CIHR)

Completed

Bone Geometry and Muscle Density Changes in Postmenopausal Women and Breast Cancer Patients Prescribed Anastrozole

Breast Cancer

Canada
Hamilton Health Sciences Corporation
McMaster University; Regional Medical Associates Research Scholarship Fund

Completed

Safety And Feasibility of Early DischargE - a Prospective And Randomized Trial of Low-risk Primary Percutaneous Coronary Intervention (PCI) Patients (SAFE-DEPART)

Myocardial Infarction

Canada
Hamilton Health Sciences Corporation
Canadian Institutes of Health Research (CIHR)

Completed

Lung Open Ventilation to Decrease Mortality in the Acute Respiratory Distress Syndrome (LOVS)

Acute Respiratory Distress Syndrome

Canada
Hamilton Health Sciences Corporation
Canadian Institutes of Health Research (CIHR)

Unknown

Quality Initiative in Rectal Cancer (QIRC) Trial

Rectal Cancer
donald whiting
Boston Scientific Corporation

Recruiting

Deep Brain Stimulation Effects in Patients With Chronic Refractory Obesity

Obesity

United States
Ottawa Heart Institute Research Corporation
Canadian Institutes of Health Research (CIHR); Heart and Stroke Foundation...

Completed

PET and Recovery Following Revascularization (PARR 2)

Coronary Artery Disease | Ventricular Dysfunction, Left

Canada
Julie Nangia
Incyte Corporation; Translational Breast Cancer Research Consortium

Recruiting

Ruxolitinib for Premalignant Breast Disease (TBCRC042)

Ductal Carcinoma In Situ | Atypical Ductal Hyperplasia | Atypical Lobular Hyperplasia | Lobular Carcinoma In Situ

United States
Treatment Research Institute
National Institute on Drug Abuse (NIDA)

Completed

Monitoring and Feedback in Substance Abuse Treatment

Substance Abuse

United States
Treatment Research Institute
National Institute on Drug Abuse (NIDA)

Completed

Linking Services to Patient Needs for Improved Patient Outcomes (CASPAR) (CASPAR)

Substance Abuse

United States
Treatment Research Institute
National Institute on Drug Abuse (NIDA)

Completed

Clinical Monitoring to Facilitate Continuous Care for Substance Abusing Clients

Substance-Related Disorders | Mental Disorders

United States
Treatment Research Institute
National Institute on Drug Abuse (NIDA)

Completed

Contingency Management for Cocaine Dependence: Cash Versus Vouchers

Substance Abuse | Substance Related Disorders | Drug Addiction

United States
Lawson Health Research Institute
London Health Sciences Centre; University of Waterloo; Medbuy Corporation

Completed

A Trial to Assess the Influence of a Pictorial Medication Calendar on Medication Taking Behaviour

Cancer | Chemotherapy | Medication Adherence

Canada
Mitsubishi Tanabe Pharma Corporation
The Research Foundation for Microbial Diseases of Osaka University

Completed

Confirmatory Study of BK1310 in Healthy Infants

Pertussis | Tetanus | Diphtheria | Bacterial Meningitis | Poliomyelitis

Japan
Mitsubishi Tanabe Pharma Corporation
The Research Foundation for Microbial Diseases of Osaka University

Completed

Safety and Efficacy of BK1310 Intramuscular Injection in Healthy Infants

Immunization

Japan
Mitsubishi Tanabe Pharma Corporation
The Research Foundation for Microbial Diseases of Osaka University

Completed

Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents

Pertussis | Tetanus | Diphtheria

Japan
Nisha Mohindra, MD
Merck Sharp & Dohme LLC; Hoosier Cancer Research Network; Celgene Corporation

Terminated

Carboplatin/Nab-Paclitaxel and Pembrolizumab in NSCLC

Non-Small Cell Lung Cancer

United States
Treatment Research Institute
National Institute on Drug Abuse (NIDA)

Completed

Evaluation of Web-Based Recovery Monitoring With Clinical Alerts

Substance Abuse

United States
Treatment Research Institute
National Institute on Drug Abuse (NIDA)

Completed

Improving Identification of Social Harm Among Substance Abusers in HIV Trials

Social Harms in Substance Users in HIV Trials | Audio Computer Assisted Self-administered Questionnaire

United States
H. Lee Moffitt Cancer Center and Research Institute
Bristol-Myers Squibb; Celgene Corporation

Completed

Avadomide (CC-122) in Combination With Nivolumab in Advanced Melanoma

Melanoma

United States
Helen S. Driver, PhD
Braebon Medical Corporation; National Research Council, Canada

Completed

Low-cost Sensor System for COVID-19 Patient Monitoring: Validation of BRAEBON Vital Signs Monitor (VTS)

COVID-19

Canada
Baxter Healthcare Corporation
German Federal Ministry of Education and Research; Gambro Dialysatoren GmbH

Completed

PERCI- Medium Cut Off (MCO) (PERCI-MCO)

Chronic Inflammation | Chronic Kidney Failure

Germany
Posit Science Corporation
University of South Florida; National Institute of Nursing Research (NINR)

Completed

HeartMapp: Assessment and Treatment for Heart Failure (HeartMapp)

Heart Failure | Cognitive Impairment

United States
Hamilton Health Sciences Corporation
McMaster University; Population Health Research Institute; Cloud DX Inc.

Not yet recruiting

Verification Protocol for the Cloud DX Vitaliti Continuous Vital Signs Monitor (VERDICT-2) (VERDICT-2)

Blood Pressure | Respiration | Temperature | Heart Rate | Oxygen Saturation | Pulse Rate

Canada
Ottawa Heart Institute Research Corporation
Ontario Ministry of Health and Long Term Care

Recruiting

Cardiac FDG PET Viability Registry (CADRE)

Heart Failure | Ischemic Heart Disease | Myocardial Dysfunction

Canada
Royal Victoria Eye and Ear Hospital
Glaukos Corporation; Centre for Eye Research Australia

Completed

A Comparison of Cataract Surgery Alone and Cataract Surgery With iStent

Glaucoma, Open-Angle

Australia
Treatment Research Institute
National Institute on Drug Abuse (NIDA)

Completed

Reducing High Risk Behavior in Treatment Court

HIV | Substance Abuse

United States
Treatment Research Institute
National Institute on Drug Abuse (NIDA)

Completed

Development of Coercion Assessment Scale (CAS)

Coercion to Participate in Research

United States
Treatment Research Institute
National Institute on Drug Abuse (NIDA)

Completed

Home-based Continuing Care for Young Adults Leaving Residential Substance Abuse Treatment (HCC)

Substance Use Disorders

United States
Hamilton Health Sciences Corporation
Institute for Clinical Evaluative Sciences; Population Health Research Institute

Completed

Myocardial Infarction Prescription Duration Adherence Study (MIPAD)

Medication Adherence

Canada
Canadian Medical and Surgical Knowledge Translation...
HLS Therapeutics, Inc; Amarin Corporation

Completed

An Investigation on the Effects of Icosapent Ethyl (VascepaTM) on Inflammatory Biomarkers in Individuals With COVID-19

COVID-19 | Inflammatory Response

Canada
Ottawa Hospital Research Institute
Baxter Healthcare Corporation; The Ottawa Hospital Academic Medical Association

Unknown

Development of a 'Phosphate Counting Program'

End Stage Renal Disease

Canada
Scripps Translational Science Institute
Michael J. Fox Foundation for Parkinson's Research; Intel Corporation

Completed

GADGET-PD Genetic and Digital Diagnosis of Essential Tremor and Parkinson's Disease Trial (GADGET-PD)

Parkinson Disease | Essential Tremor
The George Institute
National Health and Medical Research Council, Australia; Baxter Healthcare...

Completed

A Clinical Trial of IntensiVE Dialysis (ACTIVE)

End Stage Renal Disease | Renal Replacement Therapy | End Stage Kidney Disease | Renal Dialysis | Uremia

New Zealand, Canada, Australia, China
Mitsubishi Tanabe Pharma Corporation
The Research Foundation for Microbial Diseases of Osaka University

Completed

Phase 3 Study of BK1310 in Healthy Infants

Immunization; Infection

Japan
Brooklyn Urology Research Group
American Medical Systems; Richard Wolf Medical Instruments Corporation (RWMIC)

Completed

Phase 4 Study of Greenlight XPS Laser Versus BiVAP Saline Vaporization of the Prostate in Men With Symptomatic Benign Prostatic Hyperplasia

Benign Prostatic Hyperplasia (BPH)

United States

Clinical Trials Sponsored by Clintrex Research Corporation

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Greece

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations